Because concomitant proteinopathies are frequently found in dementias,45 clusterin in combination with α-synuclein could be especially useful in identifying those patients most likely to benefit from therapies targeting intraneuronal α-synuclein. The gene discussed is CLU; the disease is proteostasis deficiencies.